OpenAI GPT 5 Meets Meta’s AI Labs
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
OpenAI GPT 5 Meets Meta’s AI Labs
-
Narrated by:
-
By:
About this listen
In this episode, we discuss OpenAI’s GPT 5, Meta’s Superintelligence Labs investment, and Isomorphic Labs’ AI-driven drug discovery. OpenAI’s GPT 5 sets new benchmarks in multimodal reasoning, real-time web search, and accuracy improvements while Meta’s $14.3 billion bet on Scale AI and talent recruitment underscores its AI ambitions. We also explore Isomorphic Labs’ AlphaFold 3 platform and partnerships with Novartis and Eli Lilly to accelerate AI-driven drug discovery for cancer and immune diseases. Tune in for a deep dive into the AI breakthroughs reshaping technology and healthcare.
Help support the podcast by using our affiliate links: Eleven Labs: https://try.elevenlabs.io/ibl30sgkibkv
Disclaimer
This podcast is an independent production and is not affiliated with, endorsed by, or sponsored by OpenAI, Meta, Scale AI, Isomorphic Labs, Google DeepMind, Novartis, Eli Lilly, or any other entities mentioned unless explicitly stated. The content is for educational and entertainment purposes only and does not constitute professional, financial, or medical advice. Affiliate links help support the show at no extra cost to you."